Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-15

Clinical Trial Update: Implantation of Mesenchymal Stem Cell, Conditioned Medium, or Triamcinolone Acetonide for Keloid [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating implantation of mesenchymal stem cell, conditioned medium, or triamcinolone acetonide for keloids.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Conditioned medium (conditioned medium)
  • TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)
  • mesenchymal stem cell implantation

Snippet

Sponsor: PT. Prodia Stem Cell Indonesia | Conditions: Keloid | Phase 1, Phase 2 | Status: UNKNOWN